Schizophrenia Schizoaffective
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
TMS Related Biomarker Assessments
Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes
Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
Qualitative Study of Emotional Regulation in Schizophrenia
A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
Personalised Cognitive Remediation Therapy (pCRT)